Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (51)
  • 2024 (42)
  • 2023 (76)
  • 2022 (84)
  • 2021 (70)
  • 2020 (15)
  • 2019 (20)
  • 2018 (5)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4013)
  • Synthetic drugs (1065)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (604)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (457)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (6)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Prescription Drugs (364)
  • Recruitment/Office of Training/Graduations (2)

Drug Name

  • Oxycodone (75)
  • Opioids (57)
  • Fentanyl (53)
  • Synthetic Opioids (21)
  • Hydromorphone (18)
  • Benzodiazepines (13)
  • Methamphetamine (13)
  • Morphine (10)
  • Amphetamines (9)
  • Cocaine (8)
  • Heroin (6)
  • Methadone (5)
  • Marijuana (Cannabis) (3)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (34)
  • New England (24)
  • Seattle (23)
  • Headquarters (21)
  • Atlanta (19)
  • Miami (18)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • Omaha (10)
  • Los Angeles (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

DEA Chicago Suspends Registration Number of Suburban Chicago Physician

March 04, 2022
CHICAGO – Robert Bell, Special Agent in Charge of the U.S. Drug Enforcement Administration - Chicago Division, announced that on March 3, 2022, DEA Chicago Diversion Investigators served an Immediate Suspension Order on Faris Abusharif, M.D., for allegedly committing acts that render the continued use of his DEA Registration inconsistent...
March 04, 2022
PRESS RELEASE

Alexandria Man Sentenced for Armed Fentanyl Distribution Conspiracy

March 04, 2022
ALEXANDRIA, Va. – An Alexandria man was sentenced today to 14 years in prison for conspiracy, possession, and distribution of fentanyl and Eutylone, and being a felon in possession of a firearm during drug trafficking. According to court documents, from in or around June 2020, through at least December 2020...
March 04, 2022
PRESS RELEASE

Former Nurse at Danville Hospital Sentenced for Tampering with Prescription Opioid Drugs, Making False Statements

March 04, 2022
DANVILLE, Va. – A former registered nurse working at Sovah Health-Danville was sentenced today to 36 months in federal prison for tampering with consumer products (fentanyl and hydromorphone) and making false statements. Emilee Kathryn Poteat, 31, pleaded guilty in May 2021 to one count of tampering with consumer products (fentanyl...
March 04, 2022
PRESS RELEASE

Former Angels Communications Director Eric Kay Convicted in Tyler Skaggs Overdose Case

February 17, 2022
Dallas - An ex-employee of the Los Angeles Angles was convicted today in connection with the 2019 overdose death of Angles pitcher Tyler Skaggs, announced Eduardo A. Chávez, Special Agent in Charge of DEA Dallas/Fort Worth After less than an hour and a half of deliberation, a federal jury found...
February 17, 2022
PRESS RELEASE

Richland Naturopath Agrees to Pay $70,096 for Improper Prescription of Controlled Substances

February 16, 2022
Richland, Wash. – Judith K. Caporiccio, N.D., a Richland-based naturopathic doctor, has agreed to pay $70,096 to resolve allegations under the Controlled Substances Act and the False Claims Act, which allege that she improperly prescribed controlled substances between July 2016 and July 2021. The Controlled Substances Act regulates certain drugs...
February 16, 2022
PRESS RELEASE

Pharmacist Indicted for Tampering with a Controlled Substance

February 16, 2022
KANSAS CITY, Kan. – A federal grand jury in Kansas City returned an indictment charging a pharmacist with one count of tampering with a consumer product, one count of possession of tramadol by deception and subterfuge, one count of possession of zolpidem by deception and subterfuge, and one count of...
February 16, 2022
PRESS RELEASE

Mesa Nurse Practitioner Indicted Over Alleged Illegal Opioid Prescribing Practices

February 10, 2022
PHOENIX - Nurse Practitioner Deborah Ann Cooney, 59 years old, has been indicted on 14 criminal charges related to her alleged illegal opioid prescribing practices at a clinic she operates in Mesa, Arizona. The investigation conducted by the Phoenix Office of the Drug Enforcement Administration (DEA) developed allegations of improper...
February 10, 2022
PRESS RELEASE

DEA Houston Shuts Down Wholesale Rx Inc. Distribution Operations

February 09, 2022
HOUSTON, TX – Today, Drug Enforcement Administration Houston Division diversion investigators served an Immediate Suspension Order (ISO) that immediately suspended the DEA registration held by Wholesale Rx also known as “Tyler Pharmaceuticals” located in Cordova, TN. Wholesale Rx is suspected of diverting controlled substances onto the black market resulting in...
February 09, 2022
PRESS RELEASE

New Jersey Doctor Charged with 34 Counts of Unlawful Distribution of Controlled Substances

February 09, 2022
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a Passaic County, New Jersey, doctor was charged today with multiple counts of illegally prescribing medicines to his patients...
February 09, 2022
PRESS RELEASE

Distributor Convicted of Conspiring to Distribute Controlled Substances and Defrauding the DEA

February 02, 2022
NEW YORK – Damian Williams, the United States Attorney for the Southern District of New York announced that Laurence F. Doud III, the former Chief Executive Officer of Rochester Drug Co-Operative, Inc. (RDC), was convicted today in Manhattan federal court of conspiring to distribute unlawfully, oxycodone and fentanyl, and conspiring...
February 02, 2022
Showing 231 - 240 of 366 results

Pagination

  • First page «
  • Previous page ‹
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Current page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster